CD274 and cancer: The goal was to explore differences in terms of molecular, histological, and clinical bladder cancer subtypes, clinical risk categories, T-stage categories, pathologic grade, and PD-L1 expression that might be useful to construct a prognostic/predictive gene signature panel useful in the clinic, mostly related to cancer-specific survival.